---
category: news
title: "Trial backs Lillyâ€™s Olumiant plus remdesivir as combo COVID-19 therapy"
excerpt: "Eli Lilly says rheumatoid arthritis drug Olumiant helps speed COVID-19 recovery when added to Gilead's remdesivir by around 1 day. Will discuss emergency use with FDA"
publishedDateTime: 2020-09-16T08:46:00Z
originalUrl: "https://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/"
webUrl: "https://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/"
type: article

provider:
  name: pharmaphorum.com
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2016/06/LillYLOGO.jpg"
    width: 1800
    height: 987
    isCached: true

secured: "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;6rPZ/+uDvaDgFoqh5K/Gww=="
---

